Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 221

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Tau alteration and neuronal degeneration in tauopathies: mechanisms and models

Open access
Brandt, Roland, Hundelt, Monika, Shahani, Neelam·2005·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbadis.2004.06.018

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Research works printed but not linked: 194

  1. Binder, 1985, The distribution of tau in the mammalian central nervous system, J. Cell Biol., 101, 1371, 10.1083/jcb.101.4.1371 · DOI · Paper page
  2. Neve, 1986, Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2, Brain Res., 387, 271, 10.1016/0169-328X(86)90033-1 · DOI · Paper page
  3. Goedert, 1989, Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain, EMBO J., 8, 393, 10.1002/j.1460-2075.1989.tb03390.x · DOI · Paper page
  4. Georgieff, 1991, High molecular weight tau: preferential localization in the peripheral nervous system, J. Cell Sci., 100, 55, 10.1242/jcs.100.1.55 · DOI
  5. Couchie, 1992, Primary structure of high molecular weight tau present in the peripheral nervous system, Proc. Natl. Acad. Sci. U. S. A., 89, 4378, 10.1073/pnas.89.10.4378 · DOI · Paper page
  6. Goedert, 1992, Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system, Proc. Natl. Acad. Sci. U. S. A., 89, 1983, 10.1073/pnas.89.5.1983 · DOI · Paper page
  7. Shahani, 2002, Functions and malfunctions of the tau proteins, Cell. Mol. Life Sci., 59, 1668, 10.1007/PL00012495 · DOI · Paper page
  8. Probst, 1991, Alzheimer's disease: a description of the structural lesions, Brain Pathol., 1, 229, 10.1111/j.1750-3639.1991.tb00666.x · DOI
  9. Foster, 1997, Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference, Conference Participants, Ann. Neurol., 41, 706, 10.1002/ana.410410606 · DOI · Paper page
  10. Spillantini, 1998, Tau protein pathology in neurodegenerative diseases, Trends Neurosci., 21, 428, 10.1016/S0166-2236(98)01337-X · DOI · Paper page
  11. Crowther, 2000, Abnormal tau-containing filaments in neurodegenerative diseases, J. Struct. Biol., 130, 271, 10.1006/jsbi.2000.4270 · DOI · Paper page
  12. Nicholl, 2003, An English kindred with a novel recessive tauopathy and respiratory failure, Ann. Neurol., 54, 682, 10.1002/ana.10747 · DOI
  13. Braak, 1994, A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads, Acta Neuropathol. (Berl.), 87, 554, 10.1007/BF00293315 · DOI · Paper page
  14. Kenessey, 1993, The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments, Brain Res., 629, 40, 10.1016/0006-8993(93)90478-6 · DOI · Paper page
  15. Matsuo, 1994, Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau, Neuron, 13, 989, 10.1016/0896-6273(94)90264-X · DOI · Paper page
  16. Morishima-Kawashima, 1995, Hyperphosphorylation of tau in PHF, Neurobiol. Aging, 16, 365, 10.1016/0197-4580(95)00027-C · DOI · Paper page
  17. Hoffmann, 1997, Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites, Biochemistry, 36, 8114, 10.1021/bi970380+ · DOI
  18. Zheng-Fischhofer, 1998, Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation, Eur. J. Biochem., 252, 542, 10.1046/j.1432-1327.1998.2520542.x · DOI · Paper page
  19. Spillantini, 1998, Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau, Am. J. Pathol., 153, 1359, 10.1016/S0002-9440(10)65721-5 · DOI · Paper page
  20. Crowther, 1985, Image reconstruction of the Alzheimer paired helical filament, EMBO J., 4, 3661, 10.1002/j.1460-2075.1985.tb04132.x · DOI · Paper page
  21. Crowther, 1991, Straight and paired helical filaments in Alzheimer disease have a common structural unit, Proc. Natl. Acad. Sci. U. S. A., 88, 2288, 10.1073/pnas.88.6.2288 · DOI · Paper page
  22. Kondo, 1988, The carboxyl third of tau is tightly bound to paired helical filaments, Neuron, 1, 827, 10.1016/0896-6273(88)90130-4 · DOI · Paper page
  23. Kosik, 1988, Epitopes that span the tau molecule are shared with paired helical filaments, Neuron, 1, 817, 10.1016/0896-6273(88)90129-8 · DOI · Paper page
  24. Wischik, 1988, Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease, Proc. Natl. Acad. Sci. U. S. A., 85, 4506, 10.1073/pnas.85.12.4506 · DOI · Paper page
  25. Spillantini, 1996, Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles, Acta Neuropathol. (Berl.), 92, 42, 10.1007/s004010050487 · DOI · Paper page
  26. Hong, 1998, Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17, Science, 282, 1914, 10.1126/science.282.5395.1914 · DOI · Paper page
  27. van Swieten, 1999, Phenotypic variation in hereditary frontotemporal dementia with tau mutations, Ann. Neurol., 46, 617, 10.1002/1531-8249(199910)46:4<617::AID-ANA10>3.0.CO;2-I · doi:10.1002/1531-8249(199910)46:4<617::aid-ana10>3.0.co;2-i
  28. Lippa, 2000, Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation, Ann. Neurol., 48, 850, 10.1002/1531-8249(200012)48:6<850::AID-ANA5>3.0.CO;2-V · doi:10.1002/1531-8249(200012)48:6<850::aid-ana5>3.0.co;2-v
  29. Murrell, 1999, Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits, J. Neuropathol. Exp. Neurol., 58, 1207, 10.1097/00005072-199912000-00002 · DOI · Paper page
  30. Greenberg, 1990, A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis, Proc. Natl. Acad. Sci. U. S. A., 87, 5827, 10.1073/pnas.87.15.5827 · DOI · Paper page
  31. Goedert, 1992, Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms, Neuron, 8, 159, 10.1016/0896-6273(92)90117-V · DOI · Paper page
  32. Mulot, 1994, PHF-tau from Alzheimer's brain comprises four species on SDS-PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase-3 beta, FEBS Lett., 349, 359, 10.1016/0014-5793(94)00702-0 · DOI
  33. Spillantini, 1997, Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments, Proc. Natl. Acad. Sci. U. S. A., 94, 4113, 10.1073/pnas.94.8.4113 · DOI · Paper page
  34. Sergeant, 1997, Two-dimensional characterization of paired helical filament-tau from Alzheimer's disease: demonstration of an additional 74-kDa component and age-related biochemical modifications, J. Neurochem., 69, 834, 10.1046/j.1471-4159.1997.69020834.x · DOI
  35. Neumann, 2001, Pick's disease associated with the novel Tau gene mutation K369I, Ann. Neurol., 50, 503, 10.1002/ana.1223 · DOI
  36. Mori, 1987, Ubiquitin is a component of paired helical filaments in Alzheimer's disease, Science, 235, 1641, 10.1126/science.3029875 · DOI · Paper page
  37. Manetto, 1988, Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases, Proc. Natl. Acad. Sci. U. S. A., 85, 4501, 10.1073/pnas.85.12.4501 · DOI · Paper page
  38. Wang, 1991, Brain ubiquitin is markedly elevated in Alzheimer disease, Brain Res., 566, 146, 10.1016/0006-8993(91)91692-T · DOI
  39. Bancher, 1991, Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease, Brain Res., 539, 11, 10.1016/0006-8993(91)90681-K · DOI · Paper page
  40. Gregori, 1990, A uniform isopeptide-linked multiubiquitin chain is sufficient to target substrate for degradation in ubiquitin-mediated proteolysis, J. Biol. Chem., 265, 8354, 10.1016/S0021-9258(19)38890-8 · DOI
  41. Shimura, 2004, CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival, J. Biol. Chem., 279, 4869, 10.1074/jbc.M305838200 · DOI · Paper page
  42. De Vrij, 2001, Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death, FASEB J., 15, 2680, 10.1096/fj.01-0438com · DOI
  43. Rosso, 2003, Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study, Brain, 126, 2016, 10.1093/brain/awg204 · DOI · Paper page
  44. Lin, 2003, Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation, Am. J. Pathol., 162, 213, 10.1016/S0002-9440(10)63812-6 · DOI
  45. Adamec, 2002, P301L tauopathy: confocal immunofluorescence study of perinuclear aggregation of the mutated protein, J. Neurol. Sci., 200, 85, 10.1016/S0022-510X(02)00150-8 · DOI
  46. Novak, 1994, Truncated tau protein as a new marker for Alzheimer's disease, Acta Virol., 38, 173
  47. Mena, 1996, Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease, Acta Neuropathol. (Berl.), 91, 633, 10.1007/s004010050477 · DOI
  48. Ugolini, 1997, Co-localization of truncated tau and DNA fragmentation in Alzheimer's disease neurones, NeuroReport, 8, 3709, 10.1097/00001756-199712010-00010 · DOI
  49. Garcia-Sierra, 2003, Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease, J. Alzheimer's Dis., 5, 65, 10.3233/JAD-2003-5201 · DOI · Paper page
  50. Yang, 1995, Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments, Eur. J. Biochem., 233, 9, 10.1111/j.1432-1033.1995.009_1.x · DOI · Paper page
  51. Gamblin, 2003, Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease, Proc. Natl. Acad. Sci. U. S. A., 100, 10032, 10.1073/pnas.1630428100 · DOI · Paper page
  52. Rizzu, 2000, Mutation-dependent aggregation of tau protein and its selective depletion from the soluble fraction in brain of P301L FTDP-17 patients, Hum. Mol. Genet., 9, 3075, 10.1093/hmg/9.20.3075 · DOI
  53. Yen, 1999, FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion, FEBS Lett., 461, 91, 10.1016/S0014-5793(99)01427-1 · DOI
  54. Stanford, 2003, Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia, Brain, 126, 814, 10.1093/brain/awg090 · DOI
  55. Bramblett, 1992, Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins), Lab. Invest., 66, 212
  56. Yoshida, 1993, Tau in paired helical filaments is functionally distinct from fetal tau: assembly incompetence of paired helical filament-tau, J. Neurochem., 61, 1183, 10.1111/j.1471-4159.1993.tb03642.x · DOI · Paper page
  57. Hasegawa, 1998, Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly, FEBS Lett., 437, 207, 10.1016/S0014-5793(98)01217-4 · DOI · Paper page
  58. Dayanandan, 1999, Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation, FEBS Lett., 446, 228, 10.1016/S0014-5793(99)00222-7 · DOI · Paper page
  59. Rizzu, 1999, High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands, Am. J. Hum. Genet., 64, 414, 10.1086/302256 · DOI · Paper page
  60. Hayashi, 2002, Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation, Ann. Neurol., 51, 525, 10.1002/ana.10163 · DOI
  61. Poorkaj, 2002, An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype, Ann. Neurol., 52, 511, 10.1002/ana.10340 · DOI · Paper page
  62. Rizzini, 2000, Tau gene mutation K257T causes a tauopathy similar to Pick's disease, J. Neuropathol. Exp. Neurol., 59, 990, 10.1093/jnen/59.11.990 · DOI · Paper page
  63. Grover, 2003, A novel tau mutation in exon 9 (1260V) causes a four-repeat tauopathy, Exp. Neurol., 184, 131, 10.1016/S0014-4886(03)00393-5 · DOI
  64. Kobayashi, 2003, A novel L266V mutation of the tau gene causes frontotemporal dementia with a unique tau pathology, Ann. Neurol., 53, 133, 10.1002/ana.10447 · DOI
  65. Hogg, 2003, The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy, Acta Neuropathol. (Berl.), 106, 323, 10.1007/s00401-003-0734-x · DOI
  66. van Herpen, 2003, Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R, Ann. Neurol., 54, 573, 10.1002/ana.10721 · DOI
  67. Rosso, 2002, A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick's disease, Ann. Neurol., 51, 373, 10.1002/ana.10140 · DOI
  68. Perez, 2000, The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules, J. Neurochem., 74, 2583, 10.1046/j.1471-4159.2000.0742583.x · DOI
  69. Yoshida, 2002, Functional effects of tau gene mutations deltaN296 and N296H, J. Neurochem., 80, 548, 10.1046/j.0022-3042.2001.00729.x · DOI · Paper page
  70. Grover, 2002, Effects on splicing and protein function of three mutations in codon N296 of tau in vitro, Neurosci. Lett., 323, 33, 10.1016/S0304-3940(02)00124-6 · DOI · Paper page
  71. Nacharaju, 1999, Accelerated filament formation from tau protein with specific FTDP-17 missense mutations, FEBS Lett., 447, 195, 10.1016/S0014-5793(99)00294-X · DOI · Paper page
  72. Goedert, 1999, Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments, FEBS Lett., 450, 306, 10.1016/S0014-5793(99)00508-6 · DOI · Paper page
  73. Barghorn, 2000, Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias, Biochemistry, 39, 11714, 10.1021/bi000850r · DOI · Paper page
  74. Yen, 1999, Fibrillogenesis of tau: insights from tau missense mutations in FTDP-17, Brain Pathol., 9, 695, 10.1111/j.1750-3639.1999.tb00551.x · DOI
  75. Price, 1991, The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease, Neurobiol. Aging, 12, 295, 10.1016/0197-4580(91)90006-6 · DOI · Paper page
  76. Spillantini, 1998, Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies, Brain Pathol., 8, 387, 10.1111/j.1750-3639.1998.tb00162.x · DOI · Paper page
  77. Mirra, 1999, Tau pathology in a family with dementia and a P301L mutation in tau, J. Neuropathol. Exp. Neurol., 58, 335, 10.1097/00005072-199904000-00004 · DOI · Paper page
  78. Goedert, 1999, Tau gene mutation in familial progressive subcortical gliosis, Nat. Med., 5, 454, 10.1038/7454 · DOI · Paper page
  79. Yasuda, 2000, A novel mutation at position +12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto), Ann. Neurol., 47, 422, 10.1002/1531-8249(200004)47:4<422::AID-ANA4>3.0.CO;2-G · DOI
  80. Miyamoto, 2001, Familial frontotemporal dementia and parkinsonism with a novel mutation at an intron 10+11-splice site in the tau gene, Ann. Neurol., 50, 117, 10.1002/ana.1083 · DOI
  81. Pickering-Brown, 2002, Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene, Brain, 125, 732, 10.1093/brain/awf069 · DOI
  82. Stanford, 2000, Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations, Brain, 123, 880, 10.1093/brain/123.5.880 · DOI · Paper page
  83. Reed, 1998, The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia (“pallido-ponto-nigral degeneration”), J. Neuropathol. Exp. Neurol., 57, 588, 10.1097/00005072-199806000-00006 · DOI
  84. Delisle, 1999, A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy, Acta Neuropathol. (Berl.), 98, 62, 10.1007/s004010051052 · DOI · Paper page
  85. Iijima, 1999, A distinct familial presenile dementia with a novel missense mutation in the tau gene, NeuroReport, 10, 497, 10.1097/00001756-199902250-00010 · DOI · Paper page
  86. D'Souza, 1999, Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements, Proc. Natl. Acad. Sci. U. S. A., 96, 5598, 10.1073/pnas.96.10.5598 · DOI · Paper page
  87. Ferrer, 2003, Ubiquitin-negative mini-pick-like bodies in the dentate gyrus in p301l tauopathy, J. Alzheimer's Dis., 5, 445, 10.3233/JAD-2003-5604 · DOI
  88. Pickering-Brown, 2000, Pick's disease is associated with mutations in the tau gene, Ann. Neurol., 48, 859, 10.1002/1531-8249(200012)48:6<859::AID-ANA6>3.0.CO;2-1 · doi:10.1002/1531-8249(200012)48:6<859::aid-ana6>3.0.co;2-1
  89. Wang, 1996, Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease, Nat. Med., 2, 871, 10.1038/nm0896-871 · DOI · Paper page
  90. Sato, 2001, Analysis of N-glycans of pathological tau: possible occurrence of aberrant processing of tau in Alzheimer's disease, FEBS Lett., 496, 152, 10.1016/S0014-5793(01)02421-8 · DOI
  91. Liu, 2002, Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease, FEBS Lett., 512, 101, 10.1016/S0014-5793(02)02228-7 · DOI · Paper page
  92. Liu, 2002, Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5, Neuroscience, 115, 829, 10.1016/S0306-4522(02)00510-9 · DOI
  93. Griffith, 1995, O-linked N-acetylglucosamine is upregulated in Alzheimer brains, Biochem. Biophys. Res. Commun., 213, 424, 10.1006/bbrc.1995.2149 · DOI
  94. Guevara, 1998, Altered glycosylation pattern of proteins in Alzheimer disease, J. Neuropathol. Exp. Neurol., 57, 905, 10.1097/00005072-199810000-00003 · DOI
  95. Takahashi, 1999, Glycosylation of microtubule-associated protein tau in Alzheimer's disease brain, Acta Neuropathol. (Berl.), 97, 635, 10.1007/s004010051040 · DOI
  96. Weingarten, 1975, A protein factor essential for microtubule assembly, Proc. Natl. Acad. Sci. U. S. A., 72, 1858, 10.1073/pnas.72.5.1858 · DOI · Paper page
  97. Brion, 1985, Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study, J. Submicrosc. Cytol., 17, 89
  98. Grundke-Iqbal, 1986, Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology, Proc. Natl. Acad. Sci. U. S. A., 83, 4913, 10.1073/pnas.83.13.4913 · DOI · Paper page
  99. Pollock, 1986, Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease show antigenic determinants with microtubule-associated protein tau, Lancet, 2, 1211, 10.1016/S0140-6736(86)92212-9 · DOI
  100. Murphy, 1977, Role of tubulin-associated proteins in microtubule nucleation and elongation, J. Mol. Biol., 117, 33, 10.1016/0022-2836(77)90021-3 · DOI · Paper page
  101. Butner, 1991, Tau protein binds to microtubules through a flexible array of distributed weak sites, J. Cell Biol., 115, 717, 10.1083/jcb.115.3.717 · DOI · Paper page
  102. Brandt, 1993, Functional organization of microtubule-associated protein tau. Identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro, J. Biol. Chem., 268, 3414, 10.1016/S0021-9258(18)53710-8 · DOI · Paper page
  103. Brandt, 1993, The balance between tau protein's microtubule growth and nucleation activities: implications for the formation of axonal microtubules, J. Neurochem., 61, 997, 10.1111/j.1471-4159.1993.tb03613.x · DOI
  104. Panda, 2003, Differential regulation of microtubule dynamics by three- and four-repeat tau: implications for the onset of neurodegenerative disease, Proc. Natl. Acad. Sci. U. S. A., 100, 9548, 10.1073/pnas.1633508100 · DOI · Paper page
  105. Billingsley, 1997, Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration, Biochem. J., 323, 577, 10.1042/bj3230577 · DOI · Paper page
  106. Brandt, 1994, Orientation, assembly, and stability of microtubule bundles induced by a fragment of tau protein, Cell Motil. Cytoskelet., 28, 143, 10.1002/cm.970280206 · DOI
  107. Léger, 1997, Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau, J. Biol. Chem., 272, 8441, 10.1074/jbc.272.13.8441 · DOI
  108. Morishima-Kawashima, 1995, Proline-directed and non-proline-directed phosphorylation of PHF-tau, J. Biol. Chem., 270, 823, 10.1074/jbc.270.2.823 · DOI · Paper page
  109. Lu, 1993, Functional studies of Alzheimer's disease tau protein, J. Neurosci., 13, 508, 10.1523/JNEUROSCI.13-02-00508.1993 · DOI
  110. Iqbal, 1994, Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation, FEBS Lett., 349, 104, 10.1016/0014-5793(94)00650-4 · DOI
  111. Garver, 1996, Microtubule assembly competence analysis of freshly-biopsied human tau, dephosphorylated tau, and Alzheimer tau, J. Neurosci. Res., 44, 12, 10.1002/(SICI)1097-4547(19960401)44:1<12::AID-JNR2>3.0.CO;2-L · DOI
  112. Wang, 1996, Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1, Brain Res. Mol. Brain Res., 38, 200, 10.1016/0169-328X(95)00316-K · DOI
  113. Alonso, 1996, Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules, Nat. Med., 2, 783, 10.1038/nm0796-783 · DOI · Paper page
  114. Alonso, 1997, Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau, Proc. Natl. Acad. Sci. U. S. A., 94, 298, 10.1073/pnas.94.1.298 · DOI · Paper page
  115. Kempf, 1996, Tau binds to the distal axon early in development of polarity in a microtubule- and microfilament-dependent manner, J. Neurosci., 16, 5583, 10.1523/JNEUROSCI.16-18-05583.1996 · DOI · Paper page
  116. Cáceres, 1990, Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons, Nature, 343, 461, 10.1038/343461a0 · DOI · Paper page
  117. Tint, 1998, Acute inactivation of tau has no effect on dynamics of microtubules in growing axons of cultured sympathetic neurons, J. Neurosci., 18, 8660, 10.1523/JNEUROSCI.18-21-08660.1998 · DOI
  118. Harada, 1994, Altered microtubule organization in small-calibre axons of mice lacking tau protein, Nature, 369, 488, 10.1038/369488a0 · DOI · Paper page
  119. Dawson, 2001, Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice, J. Cell Sci., 114, 1179, 10.1242/jcs.114.6.1179 · DOI · Paper page
  120. Kanai, 1989, Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA, J. Cell Biol., 109, 1173, 10.1083/jcb.109.3.1173 · DOI · Paper page
  121. Lee, 1992, Expression of tau protein in non-neuronal cells: microtubule binding and stabilization, J. Cell Sci., 102, 227, 10.1242/jcs.102.2.227 · DOI · Paper page
  122. Takemura, 1992, Increased microtubule stability and alpha tubulin acetylation in cells transfected with microtubule-associated proteins MAP1B, MAP2 or tau, J. Cell Sci., 103, 953, 10.1242/jcs.103.4.953 · DOI · Paper page
  123. Esmaeli-Azad, 1994, Sense and antisense transfection analysis of tau function—tau influences net microtubule assembly, neurite outgrowth and neuritic stability, J. Cell Sci., 107, 869, 10.1242/jcs.107.4.869 · DOI · Paper page
  124. Brandt, 1994, Differential effect of phosphorylation and substrate modulation on tau's ability to promote microtubule growth and nucleation, J. Biol. Chem., 269, 11776, 10.1016/S0021-9258(17)32639-X · DOI
  125. Lu, 2001, Competition for microtubule-binding with dual expression of tau missense and splice isoforms, Mol. Biol. Cell, 12, 171, 10.1091/mbc.12.1.171 · DOI
  126. Arawaka, 1999, The tau mutation (val337met) disrupts cytoskeletal networks of microtubules, NeuroReport, 10, 993, 10.1097/00001756-199904060-00018 · DOI
  127. Frappier, 1999, Abnormal microtubule packing in processes of SF9 cells expressing the FTDP-17 V337M tau mutation, FEBS Lett., 455, 262, 10.1016/S0014-5793(99)00902-3 · DOI
  128. DeTure, 2000, Missense tau mutations identified in FTDP-17 have a small effect on tau–microtubule interactions, Brain Res., 853, 5, 10.1016/S0006-8993(99)02124-1 · DOI
  129. Vogelsberg-Ragaglia, 2000, Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells, Mol. Biol. Cell, 11, 4093, 10.1091/mbc.11.12.4093 · DOI
  130. DeTure, 2002, Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau, Am. J. Pathol., 161, 1711, 10.1016/S0002-9440(10)64448-3 · DOI
  131. Krishnamurthy, 2004, Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model, J. Biol. Chem., 279, 7893, 10.1074/jbc.M311203200 · DOI
  132. Edson, 1993, Actin depolymerisation induces process formation on MAP2-transfected non-neuronal cells, Development, 117, 689, 10.1242/dev.117.2.689 · DOI
  133. Léger, 1994, Identification of tau protein regions required for process formation in PC12 cells, J. Cell Sci., 107, 3403, 10.1242/jcs.107.12.3403 · DOI
  134. Knops, 1991, Overexpression of tau in a nonneuronal cell induces long cellular processes, J. Cell Biol., 114, 725, 10.1083/jcb.114.4.725 · DOI · Paper page
  135. Baas, 1991, Processes induced by tau expression in Sf9 cells have an axon-like microtubule organization, J. Cell Biol., 115, 1333, 10.1083/jcb.115.5.1333 · DOI
  136. Baas, 1990, Individual microtubules in the axon consist of domains that differ in both composition and stability, J. Cell Biol., 111, 495, 10.1083/jcb.111.2.495 · DOI · Paper page
  137. Baas, 1994, Tau confers drug stability but not cold stability to microtubules in living cells, J. Cell Sci., 107, 135, 10.1242/jcs.107.1.135 · DOI
  138. Mandell, 1996, A spatial gradient of tau protein phosphorylation in nascent axons, J. Neurosci., 16, 5727, 10.1523/JNEUROSCI.16-18-05727.1996 · DOI · Paper page
  139. Wagner, 1996, Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organization, J. Cell Sci., 109, 1537, 10.1242/jcs.109.6.1537 · DOI · Paper page
  140. Sontag, 1999, Molecular interactions among protein phosphatase 2A, tau, and microtubules, J. Biol. Chem., 274, 25490, 10.1074/jbc.274.36.25490 · DOI · Paper page
  141. Sontag, 1996, Regulation of the phosphorylation state and microtubule-binding activity of tau by protein phosphatase 2A, Neuron, 17, 1201, 10.1016/S0896-6273(00)80250-0 · DOI · Paper page
  142. Fath, 2002, Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease, J. Neurosci., 22, 9733, 10.1523/JNEUROSCI.22-22-09733.2002 · DOI · Paper page
  143. Ebneth, 1998, Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease, J. Cell Biol., 143, 777, 10.1083/jcb.143.3.777 · DOI · Paper page
  144. Stamer, 2002, Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress, J. Cell Biol., 156, 1051, 10.1083/jcb.200108057 · DOI · Paper page
  145. Williams, 2000, Tau and tau reporters disrupt central projections of sensory neurons in Drosophila, J. Comp. Neurol., 428, 630, 10.1002/1096-9861(20001225)428:4<630::AID-CNE4>3.0.CO;2-X · DOI
  146. Jackson, 2002, Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila, Neuron, 34, 509, 10.1016/S0896-6273(02)00706-7 · DOI · Paper page
  147. Kraemer, 2003, Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy, Proc. Natl. Acad. Sci. U. S. A., 100, 9980, 10.1073/pnas.1533448100 · DOI · Paper page
  148. Götz, 1995, Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform, EMBO J., 14, 1304, 10.1002/j.1460-2075.1995.tb07116.x · DOI · Paper page
  149. Ishihara, 1999, Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform, Neuron, 24, 751, 10.1016/S0896-6273(00)81127-7 · DOI · Paper page
  150. Julien, 1997, Neurofilaments and motor neuron disease, Trends Cell Biol., 7, 243, 10.1016/S0962-8924(97)01049-0 · DOI
  151. Spittaels, 1999, Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein, Am. J. Pathol., 155, 2153, 10.1016/S0002-9440(10)65533-2 · DOI · Paper page
  152. Probst, 2000, Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein, Acta Neuropathol., 99, 469, 10.1007/s004010051148 · DOI · Paper page
  153. Spittaels, 2000, Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the nervous system of human four-repeat tau transgenic mice, J. Biol. Chem., 275, 41340, 10.1074/jbc.M006219200 · DOI · Paper page
  154. Nuydens, 2002, Coexpression of GSK-3beta corrects phenotypic aberrations of dorsal root ganglion cells, cultured from adult transgenic mice overexpressing human protein tau, Neurobiol. Dis., 9, 38, 10.1006/nbdi.2001.0454 · DOI
  155. Kins, 2001, Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice, J. Biol. Chem., 276, 38193, 10.1074/jbc.M102621200 · DOI · Paper page
  156. Tanemura, 2001, Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau, Neurobiol. Dis., 8, 1036, 10.1006/nbdi.2001.0439 · DOI
  157. Tatebayashi, 2002, Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau, Proc. Natl. Acad. Sci. U. S. A., 99, 13896, 10.1073/pnas.202205599 · DOI · Paper page
  158. Allen, 2002, Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein, J. Neurosci., 22, 9340, 10.1523/JNEUROSCI.22-21-09340.2002 · DOI · Paper page
  159. Dou, 2003, Chaperones increase association of tau protein with microtubules, Proc. Natl. Acad. Sci. U. S. A., 100, 721, 10.1073/pnas.242720499 · DOI · Paper page
  160. Shimura, 2004, Binding of Tau to HSP27 leads to decreased concentration of hyperphosphorylated Tau and enhanced cell survival, J. Biol. Chem., 279, 17957, 10.1074/jbc.M400351200 · DOI · Paper page
  161. Jicha, 1997, Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau, J. Neurosci. Res., 48, 128, 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E · doi:10.1002/(sici)1097-4547(19970415)48:2<128::aid-jnr5>3.0.co;2-e
  162. Jicha, 1999, Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease, J. Neurosci. Res., 55, 713, 10.1002/(SICI)1097-4547(19990315)55:6<713::AID-JNR6>3.0.CO;2-G · DOI
  163. Cleveland, 1977, Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly, J. Mol. Biol., 116, 227, 10.1016/0022-2836(77)90214-5 · DOI · Paper page
  164. Schweers, 1994, Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure, J. Biol. Chem., 269, 24290, 10.1016/S0021-9258(19)51080-8 · DOI · Paper page
  165. Kirschner, 1986, X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation, Proc. Natl. Acad. Sci. U. S. A., 83, 503, 10.1073/pnas.83.2.503 · DOI · Paper page
  166. Berriman, 2003, Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure, Proc. Natl. Acad. Sci. U. S. A., 100, 9034, 10.1073/pnas.1530287100 · DOI · Paper page
  167. Sadqi, 2002, Alpha-helix structure in Alzheimer's disease aggregates of tau-protein, Biochemistry, 41, 7150, 10.1021/bi025777e · DOI
  168. Ledesma, 1998, Tau glycation is involved in aggregation of the protein but not in the formation of filaments, Cell. Mol. Biol., 44, 1111
  169. Alonso, 2001, Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments, Proc. Natl. Acad. Sci. U. S. A., 98, 6923, 10.1073/pnas.121119298 · DOI · Paper page
  170. Montejo de Garcini, 1986, Self assembly of microtubule associated protein tau into filaments resembling those found in Alzheimer disease, Biochem. Biophys. Res. Commun., 141, 790, 10.1016/S0006-291X(86)80242-X · DOI
  171. Wille, 1992, Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro, J. Cell Biol., 118, 573, 10.1083/jcb.118.3.573 · DOI · Paper page
  172. Pérez, 1996, Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau–tau interaction, J. Neurochem., 67, 1183, 10.1046/j.1471-4159.1996.67031183.x · DOI · Paper page
  173. Wilson, 1997, Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease, Am. J. Pathol., 150, 2181
  174. Schneider, 1999, Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments, Biochemistry, 38, 3549, 10.1021/bi981874p · DOI · Paper page
  175. Eidenmuller, 2001, Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein, Biochem. J., 357, 759, 10.1042/0264-6021:3570759 · DOI
  176. Friedhoff, 1998, A nucleated assembly mechanism of Alzheimer paired helical filaments, Proc. Natl. Acad. Sci. U. S. A., 95, 15712, 10.1073/pnas.95.26.15712 · DOI · Paper page
  177. Yao, 2003, Aggregation analysis of the microtubule binding domain in tau protein by spectroscopic methods, J. Biochem. (Tokyo), 134, 91, 10.1093/jb/mvg116 · DOI
  178. Lasn, 2001, The number of neurons in the inferior olivary nucleus in Alzheimer's disease and normal aging: a stereological study using the optical fractionator, J. Alzheimer's Dis., 3, 159, 10.3233/JAD-2001-3201 · doi:10.3233/jad-2001-3201
  179. Ferrari, 2003, beta-Amyloid induces paired helical filament-like tau filaments in tissue culture, J. Biol. Chem., 278, 40162, 10.1074/jbc.M308243200 · DOI · Paper page
  180. Cork, 1988, Neurofibrillary tangles and senile plaques in aged bears, J. Neuropathol. Exp. Neurol., 47, 629, 10.1097/00005072-198811000-00006 · DOI
  181. Nelson, 1995, Ultrastructure of neurofibrillary tangles in the cerebral cortex of sheep, Neurobiol. Aging, 16, 315, 10.1016/0197-4580(94)00175-Z · DOI
  182. Roertgen, 1996, A beta-associated cerebral angiopathy and senile plaques with neurofibrillary tangles and cerebral hemorrhage in an aged wolverine (Gulo gulo), Neurobiol. Aging, 17, 243, 10.1016/0197-4580(95)02069-1 · DOI
  183. Schultz, 2000, Filamentous tau pathology in nerve cells, astrocytes, and oligodendrocytes of aged baboons, J. Neuropathol. Exp. Neurol., 59, 39, 10.1093/jnen/59.1.39 · DOI
  184. Savory, 1998, Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease, Neurotoxicology, 19, 209
  185. Ghribi, 2002, The endoplasmic reticulum is the main site for caspase-3 activation following aluminum-induced neurotoxicity in rabbit hippocampus, Neurosci. Lett., 324, 217, 10.1016/S0304-3940(02)00147-7 · DOI
  186. Andorfer, 2003, Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms, J. Neurochem., 86, 582, 10.1046/j.1471-4159.2003.01879.x · DOI · Paper page
  187. Ishihara, 2001, Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice, Am. J. Pathol., 158, 555, 10.1016/S0002-9440(10)63997-1 · DOI · Paper page
  188. Lewis, 2000, Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein, Nat. Genet., 25, 402, 10.1038/78078 · DOI · Paper page
  189. Tanemura, 2002, Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau, J. Neurosci., 22, 133, 10.1523/JNEUROSCI.22-01-00133.2002 · DOI · Paper page
  190. Lewis, 2001, Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP, Science, 293, 1487, 10.1126/science.1058189 · DOI · Paper page
  191. Ho, 2001, Gene expression profiling of the tau mutant (P301L) transgenic mouse brain, Neurosci. Lett., 310, 1, 10.1016/S0304-3940(01)02044-4 · DOI
  192. Bird, 1999, A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L), Brain, 122, 741, 10.1093/brain/122.4.741 · DOI · Paper page
  193. Rapoport, 2002, Tau is essential to beta-amyloid-induced neurotoxicity, Proc. Natl. Acad. Sci. U. S. A., 99, 6364, 10.1073/pnas.092136199 · DOI · Paper page
  194. Lim, 2001, FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain, Mol. Cell. Neurosci., 18, 702, 10.1006/mcne.2001.1051 · DOI · Paper page

Cited by

See all 221

Metadata

Authors
Brandt, R., Hundelt, M., & Shahani, N.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher
Elsevier BV
Published
2005-01
Volume
1739
Issue
2-3
Pages
331-354
ISSN
0925-4439 (ISSN-L)
OpenAlex
W2011353108
Cited by
221
References
34
FWCI
6.65
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. https://app.cochat.ai/papers/10.1016/j.bbadis.2004.06.018
The paper
Brandt, R., Hundelt, M., & Shahani, N. (2005). Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2004.06.018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.